Trihexyphenidyl Hydrochloride Extended-Release Capsules
» Trihexyphenidyl Hydrochloride Extended-Release Capsules contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of trihexyphenidyl hydrochloride (C20H31NO·HCl).
Packaging and storage— Preserve in tight containers.
USP Reference standards 11
USP Trihexyphenidyl Hydrochloride RS Click to View Structure
A: Reduce the contents of a number of Capsules, equivalent to 20 mg of trihexyphenidyl hydrochloride, to a fine powder, and triturate with 25 mL of chloroform. Filter the mixture, and evaporate the filtrate, by gently heating, to about 10 mL. Add the solution to 100 mL of n-hexane: a white precipitate is formed. Allow the mixture to stand for 30 minutes, and collect the precipitate on a solvent-resistant membrane filter to 1-µm pore size. Wash the crystals with a small portion of n-hexane, and air-dry: the IR absorption spectrum of a potassium bromide dispersion of the crystals so obtained exhibits maxima only at the same wavelengths as that of a similar preparation of USP Trihexyphenidyl Hydrochloride RS.
B: The precipitate obtained in Identification test A responds to the tests for Chloride 191.
Dissolution 711
Medium: water; 500 mL.
Apparatus 1: 100 rpm.
Times: 3, 6, and 12 hours.
Determine the amount of C20H31NO·HCl dissolved, using the following method.
Mobile phase— Prepare a filtered and degassed mixture of acetonitrile, water, and triethylamine (920:80:0.2), and adjust with phosphoric acid to a pH of 4.0.
Standard solution— Dissolve an accurately weighed quantity of USP Trihexyphenidyl Hydrochloride RS in water, and dilute quantitatively and stepwise with water to obtain a solution having a known concentration of about 5 µg per mL.
Chromatographic system (see Chromatography 621)—The liquid chromatograph is equipped with a 210-nm detector and a 4.6-mm × 8.3-cm column that contains packing L1. The flow rate is about 2 mL per minute. Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the tailing factor for the trihexyphenidyl peak is not more than 2.8, and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Dilute the Standard solution and the solution under test with acetonitrile (1:1). Separately inject equal volumes (about 20 µL) of these solutions into the chromatograph, record the chromatograms, and measure the peak responses for trihexyphenidyl. Calculate the percentage of the labeled amount of C20H31NO·HCl dissolved.
Tolerances— The percentages of the labeled amount of C20H31NO·HCl dissolved at the times specified conform to Acceptance Table 2.
Time (hours) Amount dissolved
3 between 20% and 50%
6 between 40% and 70%
12 not less than 70%
Uniformity of dosage units 905: meet the requirements.
Mobile phase and Chromatographic system— Prepare as directed in the Assay under Trihexyphenidyl Hydrochloride.
Standard preparation— Dissolve an accurately weighed quantity of USP Trihexyphenidyl Hydrochloride RS in Mobile phase, and dilute quantitatively, and stepwise if necessary, with Mobile phase to obtain a solution having a known concentration of about 0.2 mg per mL.
Assay preparation— Fill a 500-mL volumetric flask with Mobile phase to volume. Transfer to this flask the accurately weighed contents of a counted number of Capsules, equivalent to about 100 mg of trihexyphenidyl hydrochloride. Mix, sonicate, with occasional shaking for 45 minutes, allow to stand for 15 minutes, and filter, discarding the first 5 mL of the filtrate.
Procedure— Proceed as directed for Procedure in the Assay under Trihexyphenidyl Hydrochloride. Calculate the quantity, in mg, of trihexyphenidyl hydrochloride (C20H31NO·HCl) in each of the Capsules taken by the formula:
(500C / N)(rU / rS)
in which N is the number of Capsules taken, and the other terms are as defined therein.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Hariram Ramanathan, M.S.
Associate Scientific Liaison
(SM42010) Monographs - Small Molecules 4
Reference Standards RS Technical Services
711 Margareth R.C. Marques, Ph.D.
Senior Scientific Liaison
(GCDF2010) General Chapters - Dosage Forms
USP35–NF30 Page 4948
Pharmacopeial Forum: Volume No. 31(1) Page 187